Mastermind Session: Leveraging Patient-Derived Xenograft Models to Resolve Biodistribution, Target Expression & Radiosensitivity Relationships
- Capturing clinically relevant tumor heterogeneity using low-passage, wellannotated PDX models
- Linking biodistribution, target expression, and radiosensitivity through integrated in vivo and multi-omic endpoints
- Translating PDX response data into predictive hypotheses for patient stratification and clinical trial design